3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
Stomach Neoplasms
4
Prostatic Neoplasms
4
Polycystic Ovary Syndrome
4
Neoplasms
3
Lung Neoplasms
3
Peripheral Nervous System Diseases
2
Inflammation
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Intraductal, Noninfiltrating
2
Weight Loss
1
Rectal Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Protein Deficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasm, Residual
1
Multiple Sclerosis
1
Motor Activity
1
Malnutrition
1
Lipid Metabolism Disorders
1
Infections
1
Healthy Subject
1
Interventions
Adalimumab
13
Methotrexate
11
Etanercept
10
Rituximab
5
Abatacept
5
tocilizumab
4
olokizumab
4
tofacitinib
3
golimumab
3
Infliximab
3
Tumor Necrosis Factor Inhibitors
2
Saline Solution
2
RC-18
2
Nivolumab
2
Leflunomide
2
Certolizumab Pegol
2
Antirheumatic Agents
2
veltuzumab
1
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
entecavir
1
cabozantinib
1
baricitinib
1
andecaliximab
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Arthritis, Rheumatoid
×
Fish Oils
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts